Search

Author/Creator Cusick, Thomas

1. Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of 68Ga‐PSMA PET to mpMRI. (9th July 2019)

Authors:
Scheltema, Matthijs J.; Chang, John I.; Stricker, Phillip D.; van Leeuwen, Pim J.; Nguyen, Quoc A.; Ho, Bao; Delprado, Warick; Lee, Jonathan; Thompson, James E.; Cusick, Thomas; Spriensma, Alette S.; Siriwardana, Amila R.; Yuen, Carlo; Kooner, Raji; Hruby, George; O'Neill, Gordon; Emmett, Louise
Journal:
BJU international
Issue:
Volume 124(2019)Supplement 1
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk groups. (12th July 2022)

Authors:
Roberts, Matthew J.; Chatfield, Mark D.; Hruby, George; Nandurkar, Rohan; Roach, Paul; Watts, Jo Anne; Cusick, Thomas; Kneebone, Andrew; Eade, Thomas; Ho, Bao; Nguyen, Andrew; Tang, Colin; McCarthy, Michael; Francis, Roslyn; Stricker, Phillip; Emmett, Louise
Journal:
BJU international
Issue:
Volume 130(2022)Supplement 3
Page Start:
32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol). (April 2022)

Authors:
Conduit, Ciara; Mak, Blossom; Qu, Wenjia; Lulio, Juliana Di; Burder, Ronan; Bressel, Matthias; Cusick, Thomas; Dhillon, Haryana M.; Lourenço, Richard De Abreu; Underhill, Craig; Torres, Javier; Crumbaker, Megan; Honeyball, Florian; Linton, Anthony; Allen, Ray; Davis, Ian D.; Clark, Susan J.; Horv...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prostate cancer in 432 men aged <50 years in the prostate‐specific antigen era: a new outlook. (8th November 2018)

Authors:
Gielchinsky, Ilan; Chang, John; Cusick, Thomas; Delprado, Warick; Nguyen, Quoc; Yuen, Carlo; Savdie, Richard; Böhm, Maret; Haynes, Anne‐Maree; Scheltema, Matthijs J.; Stricker, Phillip D.
Journal:
BJU international
Issue:
Volume 122(2018)Supplement 5
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer. (12th February 2020)

Authors:
Amin, Amer; Blazevski, Alexandar; Thompson, James; Scheltema, Matthijs J.; Hofman, Michael S.; Murphy, Declan; Lawrentschuk, Nathan; Sathianathen, Niranjan; Kapoor, Jada; Woo, Henry H.; Chalasani, Venu; Rasiah, Krishan; van Leeuwen, Pim J.; Tang, Reuben; Cusick, Thomas; Stricker, Phillip; Emmett,...
Journal:
BJU international
Issue:
Volume 125:Number 4(2020)
Page Start:
515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗